BCRX: BioCryst Pharmaceuticals Inc

8.22 USD 0.03 (0.36%)

Sektor: Gesundheitswesen Basis: US Dollar Gewinnwährung: US Dollar

Der Wechselkurs von BCRX hat sich für heute um -0.36% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 8.12 bis zu einem Hoch von 8.39 gehandelt.

Verfolgen Sie die BioCryst Pharmaceuticals Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.

Vollbild-Chart

BCRX News

Zacks 14:00 Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
Zacks 14:00 BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
Investing 17:32 BioCryst stock undervalued ahead of Q2 earnings, says RBC Capital
Investing 17:20 Citizens JMP downgrades Clearside Biomedical stock rating as company pauses R&D
Investing 11:46 Clearside Biomedical stock falls after announcing strategic alternatives exploration
Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
Investing 11:05 BioCryst Pharmaceuticals appoints Babar Ghias as CFO
Benzinga 14:41 BioCryst Just Ditched Its Europe Business — Here's Why Investors Are Cheering - BioCryst Pharma (NASDAQ:BCRX)
Investing 12:19 BioCryst stock rises after $264 million sale of European ORLADEYO business
Investing 11:04 BioCryst to sell European ORLADEYO business to Neopharmed for $264M
Investing 11:04 FDA extends review period for BioCryst pediatric drug application to December
Investing 11:09 BioCryst reports long-term efficacy of ORLADEYO in HAE treatment
Investing 11:06 Colombia approves BioCryst’s oral HAE treatment ORLADEYO
Investing 14:15 BioCryst at Goldman Sachs Conference: Strategic Growth and Profitability
Seeking Alpha 21:26 Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Investing 11:05 Netherlands approves BioCryst’s HAE drug ORLADEYO for reimbursement
Investing 11:36 biocryst pharmaceuticals extends cfo consulting agreement
Investing 11:32 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 11:32 BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
Investing 11:06 BioCryst reports efficacy of HAE drug across age groups
Investing 13:44 Cantor Fitzgerald maintains overweight on Metsera shares
Investing 11:28 BioCryst to Present at Upcoming Investor Conferences
Investing 11:05 BioCryst reports ORLADEYO reduces severe HAE attack rates
Benzinga 21:29 BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised Investors - BioCryst Pharma (NASDAQ:BCRX)

Tagesspanne

8.12 8.39

Jahresspanne

6.01 11.31

Vorheriger Schlusskurs: 8.09
Eröffnung: 8.25

Bid: 8.22
Ask: 8.52

Tief: 8.12
Hoch: 8.39

Volumen: 5.803 K

Tagesänderung: -0.36%
Monatsänderung: -8.46%

6-Monatsänderung: 6.48%
Jahresänderung: 12.60%

30 Juli, Mittwoch